Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-74.5
Price to sales ratio
1.39

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4118
MNOV
MediciNova, Inc. - Common Stock
1.44 USD+1.41%+3.60%+11.63%+7.46%70.88 M USD
4125
XBIT
XBiotech Inc. - Common Stock
2.27 USD-1.30%-0.44%-2.16%-33.04%69.21 M USD
4128
PLRX
Pliant Therapeutics, Inc. - Common Stock
1.12 USD-2.61%-2.61%+3.70%-30.86%69.35 M USD
4129
SPRO
Spero Therapeutics, Inc. - Common Stock
1.20 USD-0.83%-1.64%0.00%-40.30%69.88 M USD

Frequently asked questions about Champions Oncology, Inc.

What is the Champions Oncology, Inc. stock price today?

The current price of Champions Oncology, Inc. (CSBR) is 4.96. Over the past 24 hours, the stock has changed by -1.20%. Follow the CSBR chart for real-time price dynamics.

What is the stock ticker of Champions Oncology, Inc.?

Champions Oncology, Inc. trades under the ticker CSBR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Champions Oncology, Inc. stock going up?

CSBR has changed by -2.17% over the last week, -7.98% over the last month, and -25.64% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Champions Oncology, Inc.?

Champions Oncology, Inc. currently has a market capitalization of 68.91 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Champions Oncology, Inc. earnings last quarter?

Last quarter, Champions Oncology, Inc. reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Champions Oncology, Inc. revenue for the last quarter?

Champions Oncology, Inc. reported quarterly revenue of 13.84 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Champions Oncology, Inc. net income for the last quarter?

Champions Oncology, Inc. reported net income of -728 K for the last quarter. The previous quarter showed -279 K, which means net income changed by -160.93%.

How many employees does Champions Oncology, Inc. have?

As of the latest available data, Champions Oncology, Inc. has 306 employees. Workforce size can provide additional context about the company's scale and operations.

What is Champions Oncology, Inc. EBITDA?

Champions Oncology, Inc. EBITDA is -12.49 M, and its EBITDA margin is -90.31%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Champions Oncology, Inc. stock?

You can buy Champions Oncology, Inc. (CSBR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Champions Oncology, Inc. stock?

Investing in Champions Oncology, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CSBR chart and related analysis on metatrader.com as part of your research.

News